NCT00816322

The Effect of Fish Oil in Major Depressive Disorder

The Effect of Fish Oil in Major Depressive Disorder: a Double-blind Placebo-controlled Monotherapy Trail and a RCT for Recurrence Prevention

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 120 (actual)
• Sponsor: National Science and Technology Council, Taiwan · Other Government
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The whole study was divided into two major parts: (A) the 12-week, double-blind, randomized controlled, parallel omega-3 fatty acid monotherapy study in 60 patients with mild to moderate major depressive disorder. (B) The double-blind, randomized controlled, parallel omega-3 fatty acid add-on prevention study in 60 patients with major depressive disorder in recovery status. The goals of this study were to examine the therapeutic and recurrence prevention effects of omega-3 fatty acids on major depressive disorder.

Conditions

• Major Depressive Disorder

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Omega-3 fatty acids	EPA 2.1 g/d+DHA 1.1 g/d
DIETARY_SUPPLEMENT	Placebo	high oleic oil

Timeline

• Start date: 2005-01-01
• Primary completion: 2014-01-01
• Completion: 2014-12-01
• First posted: 2009-01-01
• Last updated: 2015-04-14

Locations

1 site across 1 country: Taiwan